CDK5 and Alzheimer disease: A cyclin-dependent kinase 5 (CDK5) inhibitor, LDC8, can protect against neurodegeneration, neuroinflammation and synapse density in the Aβ42-induced AD zebrafish model by modulating the phosphorylation of microtubule-associated proteins (Reinhardt et al., 2019).